[Federal Register Volume 64, Number 205 (Monday, October 25, 1999)]
[Notices]
[Page 57476]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-27813]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meeting.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Acquired Immunodeficiency Syndrome Research
Review Committee.
Date: November 5, 1999.
Time: 8 a.m. to 4:30 p.m.
Agenda: Grant applications.
Place: Crowne Plaza Hotel, Meetings Rooms 2 and 3, 14th and K
Street, NW., Washington, DC 20005.
Contact Person: :Paula S. Strickland, Ph.D., Scientific Review
Administrator, Scientific Review Program, Division of Extramural
Activities, NIAID, NIH, Room 2156, 6700-B Rockledge Drive, MSC 7610,
Bethesda, MD 20892-7610, 301-496-2550.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: October 15, 1999.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy, NIH.
[FR Doc. 99-27813 Filed 10-22-99; 8:45 am]
BILLING CODE 4140-01-M
